搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 1 小時前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), ...
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 7 小時前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
The Canadian Association of Optometrists Releases a New “GetEyeWise” Digital Campaign to Bring ...
Bastillepost· 18 小時前As May marks Vision Health Month, the Canadian Association of Optometrists (CAO) releases a digital national campaign to ...